Hôpital NOVO - Site de Pontoise
- Address
- 6 Avenue de l'Île de France, 95303 Cergy Pontoise, France
Hôpital NOVO - Site de Pontoise
Hôpital NOVO - Site de Pontoise is a clinical research facility engaged in advanced therapeutic trials across multiple medical disciplines. The center demonstrates particular expertise in immunotherapy and targeted biological treatments, conducting pivotal studies that evaluate innovative treatment strategies for complex chronic conditions and advanced-stage malignancies.
- Rheumatoid arthritis treatment optimization with biologic agents including abatacept and tocilizumab
- Immunotherapy strategies for advanced non-small cell lung cancer using nivolumab and ipilimumab combinations
- Comparative effectiveness research in patients with inadequate response to targeted therapies
The research center focuses on personalized medicine approaches for patients who have failed initial targeted treatments, particularly in autoimmune rheumatologic conditions. In oncology, the facility investigates novel stop-and-go immunotherapy protocols for stage IV lung cancer, examining whether intermittent treatment strategies can maintain disease control while potentially reducing toxicity. This work contributes to understanding optimal treatment duration and sequencing in both immune-mediated inflammatory diseases and checkpoint inhibitor therapy for advanced malignancies.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 4 by active trials.
lock +3 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 978 other sites in France
Therapeutic Area Benchmark — France
Select a therapeutic area to compare against other sites in France.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: France
Market Share
Country: France
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Hôpital NOVO - Site de Pontoise
lock Showing 1 of 4 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Randomized, Open-Label, Superiority Trial Comparing Subcutaneous Abatacept and Tocilizumab in Rheumatoid Arthritis Patients with Inadequate Response to Targeted Therapies | Groupement Des Hopitaux De L'Institut Catholique De Lille | Phase III | Not Recruiting | Jan 2018 | Jan 2026 |
IMP list
lock Showing 1 of 10 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Abatacept | 1 | Unknown | 2018-01-23 | 2018-01-23 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.